Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Mar;66(3):568-570.
doi: 10.2337/dbi16-0063.

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?

Franck Mauvais-Jarvis  1
Affiliations
Comment

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?

Franck Mauvais-Jarvis. Diabetes. 2017 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the origin of E2 in women. A: In premenopausal women, E2 is produced by the ovary and acts as a circulating hormone. Therefore, circulating E2 is the driver of E2 action in peripheral tissues. B: In postmenopausal women, ovarian E2 production is abolished. E2 is synthesized locally in extraovarian tissues from an adrenal source of dehydroepiandrosterone (DHEA) and androstenedione (4A). The local precursor of E2 is E1 after aromatization from 4A. E2 is synthesized, acts, and is metabolized locally, and therefore circulating E2 is not a driver of E2 action. E2 could be a indirect biomarker of T2D risk in postmenopausal women. ESR, estrogen receptor.
See this image and copyright information in PMC

Comment on

References

    1. Golden SH, Dobs AS, Vaidya D, et al. . Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007;92:1289–1295 - PubMed
    1. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/Progestin Intervention Trial . Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 2003;88:1646–1652 - PubMed
    1. Ding EL, Song Y, Manson JE, Rifai N, Buring JE, Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007;50:2076–2084 - PubMed
    1. Kalyani RR, Franco M, Dobs AS, et al. . The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009;94:4127–4135 - PMC - PubMed
    1. Muka T, Nano J, Jaspers L, et al. Associations of steroid sex hormones and sex hormone–binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes 2017;66:577–586 - PubMed

Publication types

LinkOut - more resources